In a phase I/II trial sponsored by Sanofi, UshStat, an EIAV lentiviral vector carrying the wild-type MYO7A gene, is being administered subretinally to 18 patients with either Usher syndrome or retinitis pigmentosa (ClinicalTrials.gov #NCT01505062). Here, MYO7A is linked to Usher syndrome.